Uses and abuses of screening tests

[1]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[2]  Kenneth F Schulz,et al.  Generation of allocation sequences in randomised trials: chance, not choice , 2002, The Lancet.

[3]  I. Chalmers,et al.  The Landscape and Lexicon of Blinding in Randomized Trials , 2002, Annals of Internal Medicine.

[4]  Richard Horton,et al.  Screening mammography—an overview revisited , 2001, The Lancet.

[5]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[6]  I. Chalmers.  Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments. , 2001, International journal of epidemiology.

[7]  Douglas G Altman,et al.  Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.

[8]  E. Krivchenia,et al.  Principles of screening. , 2001, Clinics in perinatology.

[9]  D. Moher,et al.  Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. , 2001, JAMA.

[10]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[11]  M. Trip,et al.  Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.

[12]  S. Datta,et al.  Setting the Target for a Better Cervical Screening Test: Characteristics of a Cost‐Effective Test for Cervical Neoplasia Screening , 2000, Journal of lower genital tract disease.

[13]  G. de Gaetano.  Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. , 2001, Lancet.

[14]  A. Astrup,et al.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial , 2000, The Lancet.

[15]  R. Bellomo,et al.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial , 2000, The Lancet.

[16]  Murat Emre,et al.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.

[17]  N. Wald,et al.  Antenatal and neonatal screening , 2000 .

[18]  I. Pavord,et al.  Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial , 2000, The Lancet.

[19]  G. Saade,et al.  Use of the World Wide Web in research: randomization in a multicenter clinical trial of treatment for twin-twin transfusion syndrome. , 2000, Obstetrics and gynecology.

[20]  H. Williams,et al.  How well are randomized controlled trials reported in the dermatology literature? , 2000, Archives of dermatology.

[21]  Peter C Gøtzsche,et al.  Is screening for breast cancer with mammography justifiable? , 2000, The Lancet.

[22]  David J Torgerson,et al.  Randomisation methods: concealment , 1999, BMJ.

[23]  D. Grimes,et al.  New technologies in cervical cytology screening: a word of caution. , 1999, Obstetrics and gynecology.

[24]  D. Cook,et al.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? , 1998, The Lancet.

[25]  S. Gabbe,et al.  Management of Diabetes by Obstetrician‐Gynecologists , 1998, Obstetrics and gynecology.

[26]  C. Naylor,et al.  Self-perceived health status of women three to five years after the diagnosis of gestational diabetes: a survey of cases and matched controls. , 1998, American journal of obstetrics and gynecology.

[27]  U. Haag.  Technologies for Automating Randomized Treatment Assignment in Clinical Trials , 1998 .

[28]  Kenneth F Schulz,et al.  Randomised trials, human nature, and reporting guidelines , 1996, The Lancet.

[29]  K. Schulz,et al.  Subverting randomization in controlled trials. , 1995, JAMA.

[30]  K. Schulz,et al.  Unbiased research and the human spirit: the challenges of randomized controlled trials. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[31]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[32]  Robert C. Bast,et al.  Ovarian cancer: screening, treatment, and followup. , 1995, NIH consensus statement.

[33]  D G Altman,et al.  Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. , 1994, JAMA.

[34]  David Haber,et al.  Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .

[35]  D. Grimes,et al.  The validity of the postcoital test , 1990 .

[36]  D. G. Altman,et al.  Randomisation and baseline comparisons in clinical trials , 1990, The Lancet.

[37]  M. Enkin.  A Guide to Effective Care in Pregnancy and Childbirth , 1989 .

[38]  N. Wald,et al.  Reporting the assessment of screening and diagnostic tests , 1989, British journal of obstetrics and gynaecology.

[39]  P. Gøtzsche.  Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. , 1989, Controlled clinical trials.

[40]  J M Lachin,et al.  Statistical properties of randomization in clinical trials. , 1988, Controlled clinical trials.

[41]  C B Begg,et al.  Biases in the assessment of diagnostic tests. , 1987, Statistics in medicine.

[42]  T C Chalmers,et al.  Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. , 1987, Statistics in medicine.

[43]  J. Buring,et al.  Epidemiology in Medicine , 1987 .

[44]  D. Altman.  Comparability of Randomised Groups , 1985 .

[45]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[46]  P. Lavori,et al.  Designs for experiments--parallel comparisons of treatment. , 1983, The New England journal of medicine.

[47]  S. Pocock.  Statistical Aspects of Clinical Trial Design , 1982 .

[48]  D. Sackett,et al.  Longterm follow-up of absenteeism among working men following the detection and treatment of their hypertension. , 1981, Clinical and investigative medicine. Medecine clinique et experimentale.

[49]  R B Haynes,et al.  Increased absenteeism from work after detection and labeling of hypertensive patients. , 1978, The New England journal of medicine.

[50]  A R Feinstein,et al.  XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests , 1975, Clinical pharmacology and therapeutics.

[51]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[52]  J. Yerushalmy.  Statistical problems in assessing methods of medical diagnosis, with special reference to X-ray techniques. , 1947, Public health reports.